Alshammari Q, Alshammari S, Alshammari A, Alfarhan M, Baali F
Naunyn Schmiedebergs Arch Pharmacol. 2024; .
PMID: 39476245
DOI: 10.1007/s00210-024-03564-z.
Ghazzawy H, Gouda M, Awad N, Al-Harbi N, Alqahtani M, Abdel-Salam M
Front Nutr. 2022; 9:998929.
PMID: 36386915
PMC: 9650284.
DOI: 10.3389/fnut.2022.998929.
Liu F, Bouznad N, Kaller M, Shi X, Konig J, Jaeckel S
Int J Biol Sci. 2022; 18(14):5415-5437.
PMID: 36147476
PMC: 9461672.
DOI: 10.7150/ijbs.75503.
Islam S, Ahmed M, Sonn J, Jin E, Lee Y
Int J Mol Sci. 2022; 23(6).
PMID: 35328513
PMC: 8955441.
DOI: 10.3390/ijms23063092.
Vezzani B, Carinci M, Previati M, Giacovazzi S, Della Sala M, Gafa R
Cancers (Basel). 2022; 14(5).
PMID: 35267528
PMC: 8908969.
DOI: 10.3390/cancers14051221.
Tumor suppressor p53 cross-talks with TRIM family proteins.
Liu J, Zhang C, Wang X, Hu W, Feng Z
Genes Dis. 2021; 8(4):463-474.
PMID: 34179310
PMC: 8209353.
DOI: 10.1016/j.gendis.2020.07.003.
Circulating miRNAs as Biomarkers for Mitochondrial Neuro-Gastrointestinal Encephalomyopathy.
Mencias M, Levene M, Blighe K, Bax B, The Project Group
Int J Mol Sci. 2021; 22(7).
PMID: 33916195
PMC: 8037498.
DOI: 10.3390/ijms22073681.
High-Risk HPV Oncoproteins and PD-1/PD-L1 Interplay in Human Cervical Cancer: Recent Evidence and Future Directions.
Allouch S, Malki A, Allouch A, Gupta I, Vranic S, Moustafa A
Front Oncol. 2020; 10:914.
PMID: 32695664
PMC: 7338567.
DOI: 10.3389/fonc.2020.00914.
Associations of miR-605 rs2043556 polymorphism with the susceptibility and overall survival of lung cancer in Chinese non-smoking females.
Xu X, Yin Z, Ren Y, Guan P, Zhou B
Int J Clin Exp Pathol. 2020; 11(1):438-447.
PMID: 31938129
PMC: 6957935.
The Role and Function of microRNA in the Pathogenesis of Multiple Myeloma.
Handa H, Murakami Y, Ishihara R, Kimura-Masuda K, Masuda Y
Cancers (Basel). 2019; 11(11).
PMID: 31698726
PMC: 6896016.
DOI: 10.3390/cancers11111738.
SIRT1 in the Development and Treatment of Hepatocellular Carcinoma.
Farcas M, Gavrea A, Gulei D, Ionescu C, Irimie A, Catana C
Front Nutr. 2019; 6:148.
PMID: 31608282
PMC: 6773871.
DOI: 10.3389/fnut.2019.00148.
Paracrine Induction of Epithelial-Mesenchymal Transition Between Colorectal Cancer Cells and its Suppression by a p53/miR-192/215/NID1 Axis.
Rokavec M, Bouznad N, Hermeking H
Cell Mol Gastroenterol Hepatol. 2019; 7(4):783-802.
PMID: 30831320
PMC: 6468198.
DOI: 10.1016/j.jcmgh.2019.02.003.
microRNAs and Acute Myeloid Leukemia Chemoresistance: A Mechanistic Overview.
Gabra M, Salmena L
Front Oncol. 2017; 7:255.
PMID: 29164055
PMC: 5674931.
DOI: 10.3389/fonc.2017.00255.
Modulation of the p53 family network by RNA-binding proteins.
Lucchesi C, Zhang J, Chen X
Transl Cancer Res. 2017; 5(6):676-684.
PMID: 28794999
PMC: 5546219.
DOI: 10.21037/tcr.2016.08.30.
Alkaline ceramidase 2 is a novel direct target of p53 and induces autophagy and apoptosis through ROS generation.
Wang Y, Zhang C, Jin Y, Wang , He Q, Liu Z
Sci Rep. 2017; 7:44573.
PMID: 28294157
PMC: 5353723.
DOI: 10.1038/srep44573.
Regulation of miR-34 Family in Neuronal Development.
Jauhari A, Singh T, Singh P, Parmar D, Yadav S
Mol Neurobiol. 2017; 55(2):936-945.
PMID: 28084588
DOI: 10.1007/s12035-016-0359-4.
Wnt-signalling pathways and microRNAs network in carcinogenesis: experimental and bioinformatics approaches.
Onyido E, Sweeney E, Shams Nateri A
Mol Cancer. 2016; 15(1):56.
PMID: 27590724
PMC: 5010773.
DOI: 10.1186/s12943-016-0541-3.
miR-2861 acts as a tumor suppressor via targeting EGFR/AKT2/CCND1 pathway in cervical cancer induced by human papillomavirus virus 16 E6.
Xu J, Wan X, Chen X, Fang Y, Cheng X, Xie X
Sci Rep. 2016; 6:28968.
PMID: 27364926
PMC: 4929448.
DOI: 10.1038/srep28968.
Clinical impact of L1CAM expression measured on the transcriptome level in ovarian cancer.
Abdel Azim S, Duggan-Peer M, Sprung S, Reimer D, Fiegl H, Soleiman A
Oncotarget. 2016; 7(24):37205-37214.
PMID: 27174921
PMC: 5095069.
DOI: 10.18632/oncotarget.9291.
The p53 Transcriptional Network Influences Microglia Behavior and Neuroinflammation.
Aloi M, Su W, Garden G
Crit Rev Immunol. 2016; 35(5):401-15.
PMID: 26853851
PMC: 5467747.
DOI: 10.1615/critrevimmunol.v35.i5.40.